Respiratory nurse lead Carol Stonham outlines what nurses in primary care need to know about changes in the diagnosis and ...

Combinations of LABA + LAMA + ICS in separate inhalers are used in patients with asthma and COPD to improve and control symptoms and to reduce exacerbations. The 4-year UPLIFT study provides the ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ... receptor antagonists (LAMA) to ICS + long-acting b2 agonist (LABA) combination for 'triple therapy'.

If there is an indication for an ICS, then LABA+LAMA+ICS has been shown superior ... to COPD pharmacotherapy and inadequate symptom management, heightened risk of exacerbations, increased use ...

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic ...

Phase 2b study to evaluate novel inhaled therapeutic in patients with inadequately controlled asthma despite medium-to-high dose ICS/LABA therapy Asthma, one of the most prevalent chronic ...